LADENBURG THALMANN FINANCIAL SERVICES INC. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2019$45,000
+150.0%
5,168
+209.3%
0.00%
Q3 2019$18,000
-5.3%
1,671
+13.5%
0.00%
Q2 2019$19,000
-77.6%
1,472
-32.1%
0.00%
-100.0%
Q1 2019$85,000
+608.3%
2,169
+253.8%
0.00%
Q4 2018$12,000
-62.5%
613
-11.3%
0.00%
Q3 2018$32,000
-69.5%
691
-55.3%
0.00%
-100.0%
Q2 2018$105,0000.0%1,5470.0%0.00%0.0%
Q1 2018$105,000
+176.3%
1,547
+307.1%
0.00%
Q4 2017$38,000
-15.6%
380
+1.6%
0.00%
Q3 2017$45,000
+36.4%
3740.0%0.00%
Q2 2017$33,000
+135.7%
3740.0%0.00%
Q1 2017$14,000
+27.3%
3740.0%0.00%
Q4 2016$11,000
+120.0%
374
+405.4%
0.00%
Q3 2016$5,000
+150.0%
740.0%0.00%
Q2 2016$2,0000.0%740.0%0.00%
Q1 2016$2,000
-91.3%
74
-75.3%
0.00%
Q4 2015$23,000
-57.4%
299
-57.8%
0.00%
-100.0%
Q3 2015$54,000
-29.9%
709
+7.6%
0.00%0.0%
Q2 2015$77,000
-53.9%
659
-6.9%
0.00%
-66.7%
Q1 2015$167,000
+26.5%
708
+1.3%
0.00%0.0%
Q4 2014$132,000
-42.1%
699
-26.9%
0.00%
-50.0%
Q3 2014$228,000
+5600.0%
956
+1670.4%
0.01%
Q2 2014$4,000
+300.0%
54
+671.4%
0.00%
Q1 2014$1,00070.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders